Alaunos Therapeutics Inc
Research Alaunos Therapeutics Inc (TCRT) on Bullrun: market cap USD 4.37M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerTCRT
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 4.37M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 1.01M
- Free cash flow-USD 1.03M
Valuation Snapshot
latest market cap is USD 4.37M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 5.00K | -USD 4.18M | -USD 2.97M | n/a | -2.2 | USD 1.39M | n/a | USD 2.15M |
| FY2024 | USD 10.00K | -USD 4.68M | -USD 4.97M | n/a | -2.92 | USD 1.09M | USD 0 | USD 2.06M |
| FY2023 | USD 5.00K | -USD 4.68M | -USD 30.34M | n/a | -21.97 | USD 6.06M | USD 0 | USD 6.31M |
| FY2022 | USD 2.92M | -USD 37.73M | -USD 29.45M | n/a | -2.61 | USD 39.06M | USD 16.77M | USD 38.56M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 4.37M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 7.59M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 3.06M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 16.84M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 156.26M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 235.57M | n/a | n/a | n/a |
About Alaunos Therapeutics Inc
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Alaunos Therapeutics Inc's market cap?
Alaunos Therapeutics Inc's market capitalization is USD 4.37M.
What does Alaunos Therapeutics Inc do?
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.